These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 28728156)
21. The placental vascular endothelial growth factor polymorphisms and preeclampsia/preeclampsia severity. Keshavarzi F; Mohammadpour-Gharehbagh A; Shahrakipour M; Teimoori B; Yazdi A; Yaghmaei M; Naroeei-Nejad M; Salimi S Clin Exp Hypertens; 2017; 39(7):606-611. PubMed ID: 28665739 [TBL] [Abstract][Full Text] [Related]
22. Preeclampsia is associated with ACE I/D polymorphism, obesity and oxidative damage in Mexican women. González-Garrido JA; García-Sánchez JR; Tovar-Rodríguez JM; Olivares-Corichi IM Pregnancy Hypertens; 2017 Oct; 10():22-27. PubMed ID: 29153683 [TBL] [Abstract][Full Text] [Related]
23. The effect of miR-146a rs2910164 and miR-149 rs2292832 polymorphisms on preeclampsia susceptibility. Salimi S; Eskandari F; Rezaei M; Narooei-Nejad M; Teimoori B; Yazdi A; Yaghmaei M Mol Biol Rep; 2019 Aug; 46(4):4529-4536. PubMed ID: 31264164 [TBL] [Abstract][Full Text] [Related]
24. The possible role of maternal and placental Farajian-Mashhadi F; Eskandari F; Rezaei M; Eskandari F; Najafi D; Teimoori B; Moradi-Sharbabak M; Salimi S Clin Exp Hypertens; 2020; 42(2):171-176. PubMed ID: 31006279 [No Abstract] [Full Text] [Related]
25. First-trimester serum analytes, biophysical tests and the association with pathological morphometry in the placenta of pregnancies with preeclampsia and fetal growth restriction. Odibo AO; Zhong Y; Longtine M; Tuuli M; Odibo L; Cahill AG; Macones GA; Nelson DM Placenta; 2011 Apr; 32(4):333-8. PubMed ID: 21324404 [TBL] [Abstract][Full Text] [Related]
26. The association of the placental MTHFR 3'-UTR polymorphisms, promoter methylation, and MTHFR expression with preeclampsia. Mohammadpour-Gharehbagh A; Teimoori B; Narooei-Nejad M; Mehrabani M; Saravani R; Salimi S J Cell Biochem; 2018 Feb; 119(2):1346-1354. PubMed ID: 28722783 [TBL] [Abstract][Full Text] [Related]
27. First trimester screening of maternal placental protein 13 for predicting preeclampsia and small for gestational age: in-house study and systematic review. Schneuer FJ; Nassar N; Khambalia AZ; Tasevski V; Guilbert C; Ashton AW; Morris JM; Roberts CL Placenta; 2012 Sep; 33(9):735-40. PubMed ID: 22748852 [TBL] [Abstract][Full Text] [Related]
28. Placenta-bound and body fluid PP13 and its mRNA in normal pregnancy compared to preeclampsia, HELLP and preterm delivery. Sammar M; Nisemblat S; Fleischfarb Z; Golan A; Sadan O; Meiri H; Huppertz B; Gonen R Placenta; 2011 Feb; 32 Suppl():S30-6. PubMed ID: 21257080 [TBL] [Abstract][Full Text] [Related]
29. Association between maternal single-nucleotide polymorphisms in HLA-G gene and risk of preeclampsia. Ma C; Zheng Y; Liu X; Zhang W J Matern Fetal Neonatal Med; 2022 Dec; 35(25):9195-9200. PubMed ID: 34961407 [TBL] [Abstract][Full Text] [Related]
30. First-trimester placental protein 13 screening for preeclampsia and intrauterine growth restriction. Chafetz I; Kuhnreich I; Sammar M; Tal Y; Gibor Y; Meiri H; Cuckle H; Wolf M Am J Obstet Gynecol; 2007 Jul; 197(1):35.e1-7. PubMed ID: 17618748 [TBL] [Abstract][Full Text] [Related]
31. The change in concentrations of angiogenic and anti-angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent development of preeclampsia and small-for-gestational age. Erez O; Romero R; Espinoza J; Fu W; Todem D; Kusanovic JP; Gotsch F; Edwin S; Nien JK; Chaiworapongsa T; Mittal P; Mazaki-Tovi S; Than NG; Gomez R; Hassan SS J Matern Fetal Neonatal Med; 2008 May; 21(5):279-87. PubMed ID: 18446652 [TBL] [Abstract][Full Text] [Related]
32. Correlations of MMP-9 and PPARγ gene polymorphisms with occurrence of preeclampsia. Jia JP; Wu JH; Hu JR Eur Rev Med Pharmacol Sci; 2022 Feb; 26(3):771-778. PubMed ID: 35179743 [TBL] [Abstract][Full Text] [Related]
33. First-trimester preterm preeclampsia prediction with metabolite biomarkers: differential prediction according to maternal body mass index. Tuytten R; Syngelaki A; Thomas G; Panigassi A; Brown LW; Ortea P; Nicolaides KH Am J Obstet Gynecol; 2023 Jul; 229(1):55.e1-55.e10. PubMed ID: 36539025 [TBL] [Abstract][Full Text] [Related]
34. Newborn APOE genotype influences maternal lipid profile and the severity of high-risk pregnancy - preeclampsia: Interaction with maternal genotypes as a modulating risk factor in preeclampsia. Procopciuc LM; Caracostea G; Zaharie G; Stamatian F Hypertens Pregnancy; 2015; 34(3):271-83. PubMed ID: 25806651 [TBL] [Abstract][Full Text] [Related]
36. Can Staining of Damaged Proteins in Urine Effectively Predict Preeclampsia? Sammar M; Syngelaki A; Sharabi-Nov A; Nicolaides K; Meiri H Fetal Diagn Ther; 2017; 41(1):23-31. PubMed ID: 26930075 [TBL] [Abstract][Full Text] [Related]
37. First trimester maternal serum placental protein 13 for the prediction of pre-eclampsia in women with a priori high risk. Khalil A; Cowans NJ; Spencer K; Goichman S; Meiri H; Harrington K Prenat Diagn; 2009 Aug; 29(8):781-9. PubMed ID: 19418482 [TBL] [Abstract][Full Text] [Related]
38. Impact of HOTAIR variants on preeclampsia susceptibility based on blood and placenta and in silico analysis. Mohammadpour-Gharehbagh A; Jahantigh D; Saravani M; Harati-Sadegh M; Maruie-Milan R; Teimoori B; Salimi S IUBMB Life; 2019 Sep; 71(9):1367-1381. PubMed ID: 31188529 [TBL] [Abstract][Full Text] [Related]
39. Placental protein 13 as an early predictor in Egyptian patients with preeclampsia, correlation to risk, and association with outcome. El Sherbiny WS; Soliman A; Nasr AS J Investig Med; 2012 Jun; 60(5):818-22. PubMed ID: 22460234 [TBL] [Abstract][Full Text] [Related]
40. Relationships between Dicer 1 polymorphism and expression levels in the etiopathogenesis of preeclampsia. Eskandari F; Teimoori B; Rezaei M; Mohammadpour-Gharehbagh A; Narooei-Nejad M; Mehrabani M; Salimi S J Cell Biochem; 2018 Jul; 119(7):5563-5570. PubMed ID: 29377251 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]